Select Committee · Business and Trade Committee
Brexit and the implications for UK business: Pharmaceuticals inquiry
Status: Closed
Opened: 20 Sep 2017
Closed: 14 Sep 2017
1 report
This is the pharmaceuticals strand of the Committee's Brexit and the implications for UK business inquiry . The Committee aims to establish how the interests of different sectors should best be pursued both in the negotiating process and post-Brexit and attempts to examine a range of issues relating to market access, non-tariff barriers, regulation, skills, …
Reports
| Title | HC No. | Published | Items | Response |
|---|---|---|---|---|
| 9th Report - The impact of Brexit on the pharmaceutical sec… | HC 382 | 17 May 2018 | 0 | Responded |
Oral evidence sessions
| Date | Witnesses | |
|---|---|---|
| 5 Dec 2017 | Session | View ↗ |